Literature DB >> 16982788

qnrA in CTX-M-producing Escherichia coli isolates from France.

Jean-Philippe Lavigne1, Hélène Marchandin, Julien Delmas, Nicole Bouziges, Evelyne Lecaillon, Laurent Cavalie, Hélène Jean-Pierre, Richard Bonnet, Albert Sotto.   

Abstract

By PCR, we screened for qnr genes 112 clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli collected from hospitals in France during 2004. For the first time, 7.7% of CTX-M-producing E. coli isolates presented a plasmid-mediated resistance to quinolones. All strains harbored a qnrA gene located on a sul1-type class 1 integron with similar structure to the In36 integron.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16982788      PMCID： PMC1693975          DOI： 10.1128/AAC.00904-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  44 in total

1.  Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Agnieszka Sulikowska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.

Authors:  T Spanu; F Luzzaro; M Perilli; G Amicosante; A Toniolo; G Fadda
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

4.  Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea.

Authors:  Jungmin Kim; Yu-Mi Lim; Young-Sook Jeong; Sung-Yong Seol
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.

Authors:  Hedi Mammeri; Marc Van De Loo; Laurent Poirel; Luis Martinez-Martinez; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region.

Authors:  Johann D D Pitout; Daniel B Gregson; Deirdre L Church; Sameer Elsayed; Kevin B Laupland
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 7.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

8.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

9.  Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals.

Authors:  M Edelstein; M Pimkin; I Palagin; I Edelstein; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Prevalence of plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Nancy Chow; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more
  11 in total

1.  CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Jérôme Moreau; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

2.  Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital.

Authors:  J-P Lavigne; C Defez; N Bouziges; A Mahamat; A Sotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267

3.  Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.

Authors:  Marie-Frédérique Lartigue; Catherine Zinsius; Aline Wenger; Jacques Bille; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

Review 4.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

5.  First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria.

Authors:  A Agabou; A Pantel; Z Ouchenane; N Lezzar; S Khemissi; D Satta; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-05       Impact factor: 3.267

6.  Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006.

Authors:  Hong Fang; Ferda Ataker; Göran Hedin; Kathrine Dornbusch
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

Review 7.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.

Authors:  F Robin; R Beyrouthy; S Bonacorsi; N Aissa; L Bret; N Brieu; V Cattoir; A Chapuis; H Chardon; N Degand; F Doucet-Populaire; V Dubois; N Fortineau; A Grillon; P Lanotte; D Leyssene; I Patry; I Podglajen; C Recule; A Ros; M Colomb-Cotinat; V Ponties; M C Ploy; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

9.  Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital.

Authors:  L Drieux; F Brossier; O Duquesnoy; A Aubry; J Robert; W Sougakoff; M Lecso-Bornet; V Jarlier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-12       Impact factor: 3.267

10.  Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India.

Authors:  Kesavaram Padmavathy; Krishnan Padma; Sikhamani Rajasekaran
Journal:  J Pathog       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.